Cingulate Inc. - Common Stock (CING)
4.1600
+0.00 (0.00%)
NASDAQ · Last Trade: Apr 3rd, 9:17 AM EDT

Via Benzinga · January 30, 2025

September 04, 2024 09:00 AM, Eastern
Via News Direct · September 4, 2024

A look at the top 20 most-searched tickers on Benzinga Pro for the month of August.
Via Benzinga · September 3, 2024

Via Benzinga · September 2, 2024

Cingulate shares are surging, trading over 173% higher today. Here's what's driving the movement.
Via Benzinga · August 15, 2024

Cingulate Inc. (NASDAQ: CING) shares are soaring Friday. the stock is trading with a session volume of 3.297 million shares, approaching its 100-day average volume of 3.654 million shares.
Via Benzinga · August 30, 2024

Via Benzinga · August 20, 2024

Via Benzinga · August 19, 2024

Via Benzinga · August 19, 2024

Cingulate Inc. (NASDAQ: CING) shares are on an upward trajectory Friday. It follows the announcement that Cingulate has been granted European Patent No. 3261625 for its flagship asset, CTx-1301, which is designed to treat Attention Deficit Hyperactivity Disorder (ADHD).
Via Benzinga · August 16, 2024

Via Benzinga · August 16, 2024

The Stock Whisper Index highlights five stocks seeing increased attention from Benzinga readers.
Via Benzinga · August 16, 2024

Via Benzinga · August 16, 2024

Via Benzinga · August 16, 2024

On Thursday, major U.S. indices closed higher, with the Dow Jones Industrial Average increasing by 1.4% to 40,563.06.
Via Benzinga · August 15, 2024

CING stock results show that Cingulate missed analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · August 13, 2024